AlphaCrest Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,272
| Closed | -$1.14M | – | 989 |
|
|
2022
Q3 | $1.14M | Sell |
10,272
-7,512
| -42% | -$830K | 0.07% | 529 |
|
|
2022
Q2 | $1.33M | Sell |
17,784
-7,283
| -29% | -$546K | 0.06% | 525 |
|
|
2022
Q1 | $1.96M | Buy |
25,067
+16,196
| +183% | +$1.27M | 0.11% | 251 |
|
|
2021
Q4 | $799K | Buy |
+8,871
| New | +$799K | 0.03% | 906 |
|
|
2021
Q3 | – | Sell |
-15,741
| Closed | -$1.22M | – | 1374 |
|
|
2021
Q2 | $1.22M | Sell |
15,741
-4,447
| -22% | -$346K | 0.05% | 565 |
|
|
2021
Q1 | $1.51M | Buy |
20,188
+18,883
| +1,447% | +$1.41M | 0.08% | 356 |
|
|
2020
Q4 | $222K | Sell |
1,305
-1,252
| -49% | -$213K | 0.02% | 1037 |
|
|
2020
Q3 | $359K | Sell |
2,557
-1,382
| -35% | -$194K | 0.04% | 777 |
|
|
2020
Q2 | $632K | Buy |
+3,939
| New | +$632K | 0.11% | 292 |
|
|
2020
Q1 | – | Sell |
-4,569
| Closed | -$590K | – | 1261 |
|
|
2019
Q4 | $590K | Sell |
4,569
-1,580
| -26% | -$204K | 0.05% | 678 |
|
|
2019
Q3 | $463K | Buy |
+6,149
| New | +$463K | 0.03% | 947 |
|